Therapeutic and Diagnostic Guidelines
Copyright ©The Author(s) 2022.
World J Gastroenterol. Apr 28, 2022; 28(16): 1608-1624
Published online Apr 28, 2022. doi: 10.3748/wjg.v28.i16.1608
Table 1 Levels of evidence for therapeutic studies[49]
Level
Type of evidence
1ASystematic review (with homogeneity) of RCTs
BIndividual RCT (with narrow confidence intervals)
CAll or none study
2ASystematic review (with homogeneity) of cohort studies
BIndividual Cohort study (including low quality RCT, e.g., < 80% follow-up)
C“Outcomes” research; Ecological studies
3ASystematic review (with homogeneity) of case-control studies
BIndividual Case-control study
4Case series (and poor-quality cohort and case-control study
5Expert opinion without explicit critical appraisal or based on physiology bench research or “first principles”
Table 2 Grade practice recommendations1
Grade
Level of Recommendation
Qualifying evidence
Implications for clinicians
AStrong recommendationLevel I evidence or consistent findings from several studies of levels II, III, or IVThese recommendations should be followed unless an alternative approach with clear and compelling rationale is present
BRecommendationConsistent evidence of levels II, III, or IV These recommendations should be followed but clinicians should understand that there is scope of improvement and these may be slightly modified as per patient preferences
COptionLevels II, III, or IV evidence, but findings are inconsistentThese guidelines are broad guidelines and clinicians should be flexible in their decision-making regarding appropriate practice keeping patient preferences in mind
DOptionLevel V evidence: Little or no substantial evidenceThese recommendations may be referred but clinicians should consider all other available options while making decisions